Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study
Ashu Rastogi, Richard L. Dunbar, Hemant Thacker, Jayesh Bhatt, Krupi Parmar, Deven V. Parmar
Topics & Concepts
PostprandialDiabetes mellitusInternal medicineMedicinePlaceboEndocrinologyType 2 Diabetes MellitusType 2 diabetesRandomized controlled trialAlternative medicinePathologyPeroxisome Proliferator-Activated ReceptorsDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors